The agency has been very active in whistleblower protection for the last 18 months — with seven cases generating more than $30 million in fines — and now appears to be kicking off an enforcement sweep looking at executive agreements for public companies to determine whether they somehow “inhibit” sharing information with the SEC. This is a timely issue for public company legal departments, especially since the SEC’s most recent cases have expanded what the agency thinks is problematic conduct.
Hill Country Doctor Convicted in $39M Phony Prescription Scam
Dr. David M. Young of Fredericksburg was accused of prescribing orthotic devices and genetic tests for thousands of patients he never met. He was convicted by a jury Friday and is scheduled to be sentenced in October.
Doctor Testifies He Was Duped by Con Men in $39M Phony Prescription Scam
“Do you feel like you trusted the wrong people?” one of Dr. David Young’s defense lawyers asked him in his medical fraud trial Dallas. “Absolutely,” the doctor replied.
Dallas Doctors Plead Guilty to $9M Healthcare Fraud Scheme
Drs. Desi Barroga and Deno Barroga admitted to submitting false insurance claims purporting to give patients more than 80 corticosteroid shots in a single visit. In reality, the doctors often mimicked injecting patients by placing a needle on their bodies without piercing their skin.
Office Manager for Imprisoned Telemedicine Exec Points Finger at Texas Doctor in Phony Prescription Scam
“If I sent him 25 prescriptions, within 20 or 30 minutes, they were signed,” the onetime employee of Sunrise Medical Inc. of Florida told jurors in the Dallas trial of Dr. David M. Young.
Dallas Trial Begins for Physician Indicted in $39M Medicare Fraud
Dr. David M. Young of Fredericksburg, Texas, is accused of electronically prescribing orthotic devices and genetic tests for thousands of patients he never met. U.S. District Judge Brantley Starr told the 14 jurors and alternates chosen Tuesday that the trial is expected to take about two weeks.
Is it Time to File More Motions to Dismiss in Criminal Cases?
Dismissals by district courts in federal criminal cases are rare — even more so in white collar criminal matters. That is why the recent dismissal in a securities fraud case in the Southern District of Texas is quite notable.
Testimony Ends in ExxonMobil’s $1.9B Lawsuit Against IRS
In lieu of closing arguments, the company and the U.S. government agreed to file post-trial briefs with Chief Judge David C. Godbey of the Northern District of Texas, who presided over the weeklong tax dispute trial stemming from ExxonMobil’s natural-gas mining venture with Qatar.
SCOTUS Narrows Application of Exchange Act Rule 10b-5(b) to Half-Truths
Until last week, federal circuit courts were split on whether so-called “pure omissions” could support securities fraud claims under Securities Exchange Act Rule 10b-5(b). For those not fluent in the application and enforcement of Rule 10b-5(b), its text does not exactly roll off the tongue and its concepts can be tricky to apply in practice.
ExxonMobil Demands IRS Refund, Claiming $1.9B Tax Overpayment
In a bench trial before Chief Judge David C. Godbey of the Northern District of Texas, the oil giant claims the government erred by rejecting, for tax purposes, its “partnership” with the government of Qatar in a huge natural gas project.
- « Go to Previous Page
- Go to page 1
- Interim pages omitted …
- Go to page 3
- Go to page 4
- Go to page 5
- Go to page 6
- Go to page 7
- Interim pages omitted …
- Go to page 41
- Go to Next Page »